| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 5,007 | 5,369 | 6,752 | 7,423 |
| Service | 613 | 821 | - | - |
| Hardware And Consumable Products | 1,198 | 1,151 | - | - |
| Amortization Of Acquired Intangible Assets | 181 | 433 | - | - |
| Total cost of revenues | 1,992 | 2,405 | 2,870 | 3,546 |
| Gross profit | 3,015 | 2,964 | 3,882 | 3,877 |
| Research and development | 3,328 | 3,721 | 4,108 | 5,446 |
| Sales and marketing | 4,604 | 5,231 | 5,873 | 6,733 |
| General and administrative | 4,567 | 3,212 | 3,310 | 3,728 |
| Total operating expenses | 12,499 | 12,164 | 13,291 | 15,907 |
| Operating loss | -9,484 | -9,200 | -9,409 | -12,030 |
| Interest expenses | 1,157 | - | - | - |
| Other financial expenses (income), net | 175 | - | - | - |
| Total financial expenses (income), net | -982 | -3,790 | 204 | -313 |
| Loss before taxes | -10,466 | -12,990 | -9,205 | -12,343 |
| Income tax (benefit) | - | - | 22 | -13 |
| Net loss | -10,466 | -12,990 | -9,227 | -12,330 |
| Deemed dividend (contribution) | 8,389 | 5,572 | 4,839 | 2,278 |
| Net loss attributable to common shareholders | -18,855 | -18,562 | -14,066 | -14,608 |
| Earnings per share, basic | 2.96 | 0.18 | 0.14 | 0.25 |
| Earnings per share, diluted | 2.96 | 0.18 | 0.14 | 0.25 |
| Weighted average number of shares outstanding, basic | 3,138,106 | 49,630,949 | 47,370,317 | 40,417,421 |
| Weighted average number of shares outstanding, diluted | 3,138,106 | 49,630,949 | 47,370,317 | 40,417,421 |
DarioHealth Corp. (DRIO)
DarioHealth Corp. (DRIO)